Liquid-based Anal Cytology as a Screening Tool for Prevention of Anal Cancer in at-risk Populations: A Single-Center Retrospective Analysis on 111 Patients

Abstract

Objective Squamous cell carcinoma of the anus (SCCA) is associated with human papillomavirus (HPV) infection in almost 90% of the cases. Its incidence is alarmingly high among men who have sex with men (MSM) and continues to increase at an average rate of 2% per year. The objective of the present study is to evaluate the usefulness and performance of liquid-based anal cytology as a screening tool for prevention and early detection of SCCA in a cohort of at-risk men.

Method We conducted a retrospective study including 111 MSM, aged between 22 and 62 years old, who underwent anal cytological screening with a liquid-based Pap test at our sexually transmitted diseases (STDs) clinic from January 2015 to March 2017.

Results Out of 111 anal smears, 57 (51,4%) resulted negative, 42 (37,8%) abnormal, and 12 (10,8%) unsatisfactory for the cytological evaluation. Only patients with an abnormal cytology underwent anoscopy and subsequent biopsy. The histological results were as follows: negative for squamous intraepithelial lesion (SIL) in 5 cases, low-grade SIL (L-SIL) in 21, high-grade SIL (H-SIL) in 5, SCCA in 1. Five patients had a normal anoscopy and biopsy was not taken.

Conclusion Liquid-based cytology, reducing the “darkening factors” typical for the conventional smears, has a higher positive predictive value than the traditional technique. Moreover, a cytological diagnosis of atypical squamous cells of undetermined significance (ASC-US) or L-SIL may hide a severe dysplasia or even a carcinoma. Thus, all patients with an abnormal anal cytology at any grade should be considered for anoscopy.

Keywords

anal cancer - anal cytology - liquid-based cytology - pap test - screening

Publikationsverlauf

Eingereicht: 31. Dezember 2020

Angenommen: 15. Juni 2021

Artikel online veröffentlicht:
13. Dezember 2021

• References

• 1 de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017; 141 (04) 664-670
• 2 Viens LJ, Henley SJ, Watson M. et al. Human Papillomavirus-Associated Cancers - United States, 2008-2012. MMWR Morb Mortal Wkly Rep 2016; 65 (26) 661-666
• 3 Cancer Stat Facts. Anal Cancer (National Cancer Institute Web site). Accessed March 18, 2018 at: https://seer.cancer.gov/statfacts/anus.html
• 4 Hidalgo-Tenorio C, Gil-Anguita C, Ramírez-Taboada J. et al. Risk factors for infection by oncogenic human papillomaviruses in HIV-positive MSM patients in the ART era (2010-2016). Medicine (Baltimore) 2017; 96 (39) e8109
• 5 Silverberg MJ, Lau B, Justice AC. et al; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54 (07) 1026-1034
• 6 Powles T, Robinson D, Stebbing J. et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009; 27 (06) 884-890
• 7 Leeds IL, Fang SH. Anal cancer and intraepithelial neoplasia screening: A review. World J Gastrointest Surg 2016; 8 (01) 41-51
• 8 Nelson RA, Levine AM, Bernstein L, Smith DD, Lai LL. Changing patterns of anal canal carcinoma in the United States. J Clin Oncol 2013; 31 (12) 1569-1575
• 9 Pisano L, Tiradritti L, Lorenzoni E. et al. Pap smear in the prevention of HPV-related anal cancer: preliminary results of the study in a male population at risk. G Ital Dermatol Venereol 2016; 151 (06) 619-627
• 10 Glynne-Jones R, Nilsson PJ, Aschele C. et al. Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014 Sep;25 Suppl 3:iii10-20
• 11 Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011; 119 (01) 5-19
• 12 Liszewski W, Ananth AT, Ploch LE, Rogers NE. Anal Pap smears and anal cancer: what dermatologists should know. J Am Acad Dermatol 2014; 71 (05) 985-992
• 13 Jin F, Grulich AE, Poynten IM. et al; SPANC Study Team. The performance of anal cytology as a screening test for anal HSILs in homosexual men. Cancer Cytopathol 2016; 124 (06) 415-424
• 14 Darragh TM, Colgan TJ, Cox JT. et al; Members of LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 2012; 136 (10) 1266-1297
• 15 Clavero O, McCloskey J, Molina VM. et al. Squamous intraepithelial lesions of the anal squamocolumnar junction: Histopathological classification and HPV genotyping. Papillomavirus Res 2017; 3: 11-17
• 16 Doorbar J. Papillomavirus life cycle organization and biomarker selection. Dis Markers 2007; 23 (04) 297-313
• 17 Schlecht HP, Fugelso DK, Murphy RK. et al. Frequency of occult high-grade squamous intraepithelial neoplasia and invasive cancer within anal condylomata in men who have sex with men. Clin Infect Dis 2010; 51 (01) 107-110
• 18 Pimenoff VN, Félez-Sánchez M, Tous S. et al. Disagreement in high-grade/low-grade intraepithelial neoplasia and high-risk/low-risk HPV infection: clinical implications for anal cancer precursor lesions in HIV-positive and HIV-negative MSM. Clin Microbiol Infect 2015; 21 (06) 605.e11-605.e19
• 19 McCloskey JC, Metcalf C, French MA, Flexman JP, Burke V, Beilin LJ. The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized. Int J STD AIDS 2007; 18 (08) 538-542
• 20 Richel O, Quint KD, Lindeman J. et al. One lesion, one virus: individual components of high-grade anal intraepithelial neoplasia in HIV-positive men contain a single HPV type. J Infect Dis 2014; 210 (01) 111-120
• 21 Darragh TM, Jay N, Tupkelewicz BA, Hogeboom CJ, Holly EA, Palefsky JM. Comparison of conventional cytologic smears and ThinPrep preparations from the anal canal. Acta Cytol 1997; 41 (04) 1167-1170
• 22 Sherman ME, Friedman HB, Busseniers AE, Kelly WF, Carner TC, Saah AJ. Cytologic diagnosis of anal intraepithelial neoplasia using smears and cytyc thin-preps. Mod Pathol 1995; 8 (03) 270-274
• 23 Phanuphak N, Teeratakulpisarn N, Lim C. et al. Comparable performance of conventional and liquid-based cytology in diagnosing anal intraepithelial neoplasia in HIV-infected and -uninfected Thai men who have sex with men. J Acquir Immune Defic Syndr 2013; 63 (04) 464-471
• 24 Solomon D, Davey D, Kurman R. et al; Forum Group Members, Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287 (16) 2114-2119
• 25 Ronco G, Confortini M, Maccalini V. et al. Uso della citologia in fase liquida nello screening dei precursori del cancro del collo dell'utero. Epidemiol Prev 2012; 5 (S2): e1-33
• 26 Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006; 43 (02) 223-233
• 27 Arain S, Walts AE, Thomas P, Bose S. The Anal Pap Smear: Cytomorphology of squamous intraepithelial lesions. Cytojournal 2005; 2 (01) 4
• 28 Weis SE, Vecino I, Pogoda JM. et al. Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum 2011; 54 (04) 433-441
• 29 Repiso Jiménez JB, Frieyro-Elicegui M, Padilla-España L, Palma-Carazo F, de la Torre Lima J, Rivas-Ruiz F. Anal intraepithelial neoplasia in a sexually transmitted diseases outpatient clinic: correlation with cytological screening. J Eur Acad Dermatol Venereol 2014; 28 (05) 658-661
• 30 ASCUS-LSIL Traige Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003; 188 (06) 1393-1400